Ad is loading...
ARAY
Price
$1.70
Change
-$0.04 (-2.30%)
Updated
Nov 15 closing price
66 days until earnings call
LH
Price
$235.21
Change
-$2.97 (-1.25%)
Updated
Nov 15 closing price
81 days until earnings call
Ad is loading...

ARAY vs LH

Header iconARAY vs LH Comparison
Open Charts ARAY vs LHBanner chart's image
Accuray
Price$1.70
Change-$0.04 (-2.30%)
Volume$639.64K
CapitalizationN/A
Laboratory
Price$235.21
Change-$2.97 (-1.25%)
Volume$2.05M
CapitalizationN/A
ARAY vs LH Comparison Chart
Loading...
ARAY
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
LH
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
ARAY vs. LH commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARAY is a Sell and LH is a Sell.

COMPARISON
Comparison
Nov 18, 2024
Stock price -- (ARAY: $1.70 vs. LH: $235.21)
Brand notoriety: ARAY and LH are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: ARAY: 99% vs. LH: 330%
Market capitalization -- ARAY: $244.95M vs. LH: $18.37B
ARAY [@Medical Specialties] is valued at $244.95M. LH’s [@Medical Specialties] market capitalization is $18.37B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.03B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ARAY’s FA Score shows that 0 FA rating(s) are green whileLH’s FA Score has 4 green FA rating(s).

  • ARAY’s FA Score: 0 green, 5 red.
  • LH’s FA Score: 4 green, 1 red.
According to our system of comparison, LH is a better buy in the long-term than ARAY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARAY’s TA Score shows that 3 TA indicator(s) are bullish while LH’s TA Score has 6 bullish TA indicator(s).

  • ARAY’s TA Score: 3 bullish, 6 bearish.
  • LH’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, LH is a better buy in the short-term than ARAY.

Price Growth

ARAY (@Medical Specialties) experienced а -20.93% price change this week, while LH (@Medical Specialties) price change was -2.96% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -4.23%. For the same industry, the average monthly price growth was -2.87%, and the average quarterly price growth was -6.14%.

Reported Earning Dates

ARAY is expected to report earnings on Jan 22, 2025.

LH is expected to report earnings on Feb 06, 2025.

Industries' Descriptions

@Medical Specialties (-4.23% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LH($18.4B) has a higher market cap than ARAY($245M). LH YTD gains are higher at: 4.533 vs. ARAY (-39.929). LH has higher annual earnings (EBITDA): 1.35B vs. ARAY (5.93M). LH has more cash in the bank: 537M vs. ARAY (72.8M). ARAY has less debt than LH: ARAY (202M) vs LH (5.95B). LH has higher revenues than ARAY: LH (12.2B) vs ARAY (447M).
ARAYLHARAY / LH
Capitalization245M18.4B1%
EBITDA5.93M1.35B0%
Gain YTD-39.9294.533-881%
P/E RatioN/A49.97-
Revenue447M12.2B4%
Total Cash72.8M537M14%
Total Debt202M5.95B3%
FUNDAMENTALS RATINGS
ARAY vs LH: Fundamental Ratings
ARAY
LH
OUTLOOK RATING
1..100
2723
VALUATION
overvalued / fair valued / undervalued
1..100
83
Overvalued
15
Undervalued
PROFIT vs RISK RATING
1..100
10030
SMR RATING
1..100
9579
PRICE GROWTH RATING
1..100
6430
P/E GROWTH RATING
1..100
5811
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

LH's Valuation (15) in the Servicestothe Health Industry industry is significantly better than the same rating for ARAY (83) in the Medical Specialties industry. This means that LH’s stock grew significantly faster than ARAY’s over the last 12 months.

LH's Profit vs Risk Rating (30) in the Servicestothe Health Industry industry is significantly better than the same rating for ARAY (100) in the Medical Specialties industry. This means that LH’s stock grew significantly faster than ARAY’s over the last 12 months.

LH's SMR Rating (79) in the Servicestothe Health Industry industry is in the same range as ARAY (95) in the Medical Specialties industry. This means that LH’s stock grew similarly to ARAY’s over the last 12 months.

LH's Price Growth Rating (30) in the Servicestothe Health Industry industry is somewhat better than the same rating for ARAY (64) in the Medical Specialties industry. This means that LH’s stock grew somewhat faster than ARAY’s over the last 12 months.

LH's P/E Growth Rating (11) in the Servicestothe Health Industry industry is somewhat better than the same rating for ARAY (58) in the Medical Specialties industry. This means that LH’s stock grew somewhat faster than ARAY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ARAYLH
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
43%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
80%
Bearish Trend 3 days ago
55%
Momentum
ODDS (%)
Bearish Trend 3 days ago
89%
Bullish Trend 3 days ago
62%
MACD
ODDS (%)
Bearish Trend 3 days ago
79%
Bullish Trend 3 days ago
71%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
80%
Bearish Trend 3 days ago
52%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
80%
Bullish Trend 3 days ago
58%
Advances
ODDS (%)
Bullish Trend 10 days ago
76%
Bullish Trend 5 days ago
63%
Declines
ODDS (%)
Bearish Trend 3 days ago
79%
Bearish Trend 3 days ago
50%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
80%
Bearish Trend 3 days ago
50%
Aroon
ODDS (%)
N/A
Bullish Trend 3 days ago
52%
View a ticker or compare two or three
Ad is loading...
ARAY
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
LH
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
UNM73.190.95
+1.32%
Unum Group
FNGR1.96-0.03
-1.51%
FingerMotion
NBY0.71-0.01
-1.95%
NovaBay Pharmaceuticals
MANU16.96-0.40
-2.30%
Manchester United PLC
MLYS11.48-0.69
-5.67%
Mineralys Therapeutics

ARAY and

Correlation & Price change

A.I.dvisor indicates that over the last year, ARAY has been loosely correlated with BRKR. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if ARAY jumps, then BRKR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARAY
1D Price
Change %
ARAY100%
-2.30%
BRKR - ARAY
41%
Loosely correlated
-5.85%
BNGO - ARAY
39%
Loosely correlated
-3.83%
IQV - ARAY
38%
Loosely correlated
-5.06%
LH - ARAY
38%
Loosely correlated
-1.25%
UTMD - ARAY
38%
Loosely correlated
-0.71%
More

LH and

Correlation & Price change

A.I.dvisor indicates that over the last year, LH has been loosely correlated with DGX. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is some statistical probability that if LH jumps, then DGX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LH
1D Price
Change %
LH100%
-1.25%
DGX - LH
66%
Loosely correlated
+2.30%
TFX - LH
43%
Loosely correlated
+0.90%
QGEN - LH
40%
Loosely correlated
-1.95%
CDNA - LH
39%
Loosely correlated
-1.76%
CRL - LH
39%
Loosely correlated
-4.65%
More